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Scope: Promoting the development of brown or beige adipose tissue may protect against
obesity and related metabolic features, and potentially underlies protective effects of genistein
in mice.
Methods and results: We observed that application of genistein to 3T3-L1 adipocytes changed
the lipid distribution from large droplets to a multilocular distribution, reduced mRNAs in-
dicative of white adipocytes (ACC, Fasn, Fabp4, HSL, chemerin, and resistin) and increased
mRNAs that are a characteristic feature of brown/beige adipocytes (CD-137 and UCP1). Tran-
scripts with a role in adipocyte differentiation (Cebp, Pgc1, Sirt1) peaked at different times
after application of genistein. These responses were not affected by the estrogen receptor (ER)
antagonist fulvestrant, revealing that this action of genistein is not through the classical ER
pathway. The Sirt1 inhibitor Ex-527 curtailed the genistein-mediated increase in UCP1 and
CebpmRNA, revealing a role for Sirt1 in mediating the effect. Baseline oxygen consumption
and the proportional contribution of proton leak to maximal respiratory capacity was greater
for cells exposed to genistein, demonstrating greater mitochondrial uncoupling.
Conclusions: We conclude that genistein acts directly on adipocytes or on adipocyte progenitor
cells to programme the cells metabolically to adopt features of beige adipocytes. Thus, this
natural dietary agent may protect against obesity and related metabolic disease.
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Brown adipose tissue / Estrogen receptor / Genistein / SIRT1 / White adipose tissue
1 Introduction
Electron transport by the mitochondrial respiratory chain
generates a proton gradient that is used to synthesise ATP.
In the mitochondria of brown adipose tissue (BAT) this func-
tion is uncoupled from ATP synthesis by the action of un-
coupling protein 1 (Ucp1/UCP1), hence dissipating energy
through nonshivering thermogenesis. Transgenic mouse
models show that BAT protects against diet-induced obesity,
insulin resistance and type 2 diabetes [1]. Radionuclide la-
belling studies show that BAT stimulated by cold acclimation
is detectable in some human adults [2] and was associated
with a healthier metabolic phenotype including lower BMI,
fat mass, blood glucose, and cholesterol [3, 4]. Differences in
the adipokine profile of brown versus white adipocytes are
likely important drivers of many of these effects. There is
Correspondence: Professor Dianne Ford
E-mail: dianne.ford@northumbria.ac.uk
also a compelling argument that promoting the development
of BAT could be a strategy to maximize the benefits of a low
protein, high carbohydrate diets. Careful analysis of studies
in rodents and insects shows that such diets robustly pro-
mote longevity, and observational studies in human support
this notion. However the diets with this composition often
drive increased food intake and hence a gain in body fat [5].
Promoting the development and/or activity of BAT is thus a
potential approach to curb obesity and associated metabolic
symptoms.
Cells that have features of brown adipocytes, including
small mutilocular lipid droplets and higher Ucp1 expres-
sion associated with mitochondrial uncoupling, have been
observed in depots of white adipose tissue (WAT). For exam-
ple, cold exposure induced adipocytes that expressed Ucp1
in most depots of WAT in mice [6–8]. Terms including brite
(brown in white) or beige adipocytes are used to describe
these cells. Beige and brown adipocytes appear to be distin-
guished by several features. Beige adipocytes express Ucp1
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at high levels only in response to stimulation by factors that
include PPAR-ɣ and -adrenergic agonists. Also, the two dif-
ferent cell types arise from different precursors. It appears
that most brown adipocytes, like skeletal muscle cells, de-
rive from Myf5-expressing mesodermal precursors, whereas
it has been shown that beige adipocytes originate from pre-
cursors with no history of Myf5 expression, indicative of a
common lineage with white adipocytes. However, this po-
larity in origin between brown and beige adipocytes is not
absolute, since white adipocytes derived from precursors that
express Myf5 have been observed in some adipose tissue de-
pots [9, 10].
Beige adipocytes in WATmost likely result from differen-
tiation of precursors [11]. However, the possibility of transdif-
ferentiation cannot be excluded. The precursors from which
white and beige adipocytes originate appear distinct. The ex-
pression of the markers Cd137 is among features that distin-
guish beige precursors from those of white adipocytes [12].
In humans multipotent precursor cells with the capacity to
differentiate into cells with features of beige adipocytes have
been isolated from adult human subcutaneous WAT, includ-
ing abdominal fat [13]. Thus, there is good support for the idea
that dietary/pharmaceutical agents could induce the appear-
ance of beige adipocytes in human WAT depots and hence
confer metabolic benefit.
The isoflavone genistein is a plant polyphenol. Soyabeans
are a particularly rich dietary source of genistein. The com-
pound is similar structurally to the mammalian hormone
17- estradiol; thus it belongs to the group of compounds
termed phytoestrogens. A large body of research on genis-
tein, soya derivatives (in particular soya protein) and on soya-
based foods has uncovered evidence of potential beneficial
actions against a range of conditions. The evidence for bene-
ficial effects on cardiovascular health and protection against
cancer [14] is substantial whereas the evidence that genistein
can influence fat deposition and other (non-cardiovascular)
features of metabolic health is less robust. However observa-
tions made in rodents show variously that genistein alone or
as a crude extract with other polyphenols can have an effect
on energy expenditure, UCP expression and protect against
the obesogenic effect of a high calorie diet [15–20]. We hy-
pothesised that genistein affects white adipocyte phenotype
to promote beneficial changes in physiology. We thus stud-
ied effects of genistein on cultured white adipocytes using
the well-characterized 3T3-L1 cell line model.
2 Materials and methods
2.1 Cell culture and treatment
All reagents for cell culture and treatment were pur-
chased from Sigma. 3T3-L1 cells were grown in pre-
adipocytemedium (DMEM, 10% calf serum and 1%pencillin
streptomycin) in 6-well plates (for extraction of RNA) or in
Seahorse V7 cell plates (for measurement of mitochondrial
function). Forty eight hours after cells reached confluence,
taken as day 0, cells were induced to differentiate by us-
ing pre-adipocyte medium supplemented with 500 M
3-isobutyl-1 methylxanthine (IBMX), 10g/mL insulin,
250 nM dexmethasone, 8 g/mL biotin, and 4 g/mL pan-
tothenic acid. After a further 48 h, this medium was replaced
with pre-adipocyte medium fortified with 10 g/mL insulin,
8g/mL biotin, and 4g/mL pantothenic acid and cells were
incubated for a further 48 h. Thereafter, cellsweremaintained
in mature adipocyte medium (0.2 g/mL insulin, 8 g/mL
biotin, and 4 g/mL pantothenic acid), which was replaced
every 2 days until the end of the experiment. Normally lipid
droplets began to appear 5–6 days after inducing differentia-
tion. Genistein and fulvestrant were added as 100× solutions
in DMSO at the point where differentiation was induced and
an equal volume of DMSO was added to control cells. These
media were replaced every 2 days.
For staining with Oil Red O cells were washed with warm
PBS, fixed with 10% neutral formaldehyde for 2–3 h at room
temperature then rinsed quicklywith 60% isopropanol and al-
lowed to dry. Cells were then overlaid with Oil Red O (Sigma;
0.5% w/v diluted 3:2 in double distilled water) and incubated
for 2–3 h at room temperature before washing 3–4 times
with double distilled water and photographing under a light
microscope.
2.2 RNA extraction and RT-qPCR
Total RNA was extracted using TRIzol (Life Technologies)
then the PureLinkTM RNA Mini Kit (Life Technologies), fol-
lowing the manufacturer’s protocol. Reverse transcription
was carried out using SuperscriptTM III Reverse Transcrip-
tase (Life Technologies) according to the manufacturer’s pro-
tocol and using a 20 L reaction volume containing 0.5-1 g
RNA with 150 ng random primers (Promega), 10 M dNTPs
(Bioline), and 40 U RNase Inhibitor (Promega).
PCR reactions were performed in 10 L volumes using
SYBRGreen IMaster Mix (Roche) with each primer (Table 1)
at a concentration of 0.05 M. Cycling parameters were 95˚C
for 5 min, followed by 45–55 cycles of 95˚C for10 s, 55–60˚C
for 10 s, 72˚C for 15 s. Relative transcript quantities were
calculated using the 2Ct method using Top1 and NONO as
reference genes.
2.3 Measurement of mitochondrial function
Mitochondrial function was measured using the Seahorse
XF-24 analyser (Seahorse Bioscience). Measurements were
made on day 12 after inducing differentiation. The cartridge
was hydrated with calibration buffer (Seahorse Bioscience)
in a non-CO2 incubator at 37C for approximately 4–5 h be-
fore use. Solutions for injection were prepared in the assay
medium, which was DMEM (Sigma, D-5030) with 5 mM
D-glucose (Sigma), 2% L-Glutamax (Life Technologies), 3%
C© 2016 The Authors. Molecular Nutrition & Food Research Published by Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim. www.mnf-journal.com
Mol. Nutr. Food Res. 61, 2, 2017, 1600574 (3 of 10) 1600574
Table 1. Primers and thermal cycling parameters used for RT-qPCR. Sequences are in the 5’-3’ direction and subscript numerals refer to
positions within the sequences deposited under the stated Genbank accession numbers. Forward (5’) then reverse (3’) primer
sequences are stated in each case
Gene Transcript
Genbank
accession number
Primer sequences Anneal
temp.
(C)
Holding times (at
95C; annealing
temperature; 72C)
Number
of cycles
Acaca NM_133360.2 2587ATGTCCTGGATAACCTGGTC2606
2710GATATCCTGCAGCTCTAGCA2691
55 10 s; 5 s; 10 s 45
Fasn NM_007988.3 615GTGGACATGGTCACAGATG634
770CATAGCTGACTTCCAACAGC751
55 10 s; 5 s; 10 s 45
Fabp4 NM_024406.2 297GACAGGAAGGTGAAGAGCAT316
411GCCTTTCATAACACATTCCAC391
55 10 s; 5 s; 10 s 45
Lipe NM_010719.5 1951GTCAGTGCCTATTCAGGGAC1970
2071AGTTGAGCCATGAGGAGGC2053
55 10 s; 5 s; 10 s 45
Rarres2 NM_027852.2 231CTGTGCAGTTGGCCTTCCAAG251
359GGTTTGATTGTGCACTCCGG340
55 10 s; 5 s; 10 s 45
Retn NM_022984.4 38CAGAACTGAGTTGTGTCCTGC58
165CTTGTCGATGGCTTCATCGATG144
55 10 s; 5 s; 10 s 45
Sirt1 NM_019812.3 777GCTGTGAAGTTACTGCAGG795
874GCAAGGCGAGCATAGATAC856
56 10 s; 5 s; 10 s 45
Cebpb NM_009883.3 830CAAGGCCAAGATGCGCAAC848
944GCAGCTGCTTGAACAAGTTC925
56 10 s; 5 s; 10 s 45
Ppargc1a NM_008904.2 2151CAATTGAAGAGCGCCGTGTG2168
2296GTCACAGGTGTAACGGTAGGTG2275
55 10 s; 5 s; 10 s 45
Ucp1 NM_009463.3 563CCTGCCTCTCTCGGAAACAA582
618TGTAGGCTGCCCAATGAACA599
60 10 s; 5 s; 10 s 55
Tnfrsf9 NM_011612.2 160TCATTGTGCTGCTGCTAGTGG180
316CTGCACACACTCTGCAGATGT296
55 10 s; 5 s; 10 s 45
Nono NM_023144.2 1396TGCTCCTGTGCCACCTGGTACTC1418
1544CCGGAGCTGGACGGTTGAATGC1523
55 10 s; 5 s; 10 s 45
TOP1 NM_003286.2 Human TOP1 Primer Mix (HK-SY-hu-1200;
Primer Design)
60 10 s; 5 s; 10 s 45
calf serum (Sigma), 1% sodium pyruvate (Life Technolo-
gies). Cells were incubated in assay medium in a non-CO2
incubator at 37C for 1 h before use. The following drugs
were injected sequentially: oligomycin (1 g/mL), TTNPN
(10 M), FCCP (2.5 M), antimycin A (2.5 M) (all from
Sigma). Proton leak was calculated as the difference in oxy-
gen consumption rate (OCR) between cells after the addi-
tion of oligomycin and after the addition of antimycin. Max-
imum mitochondrial oxygen consumption was calculated as
the difference in OCR between cells after the addition of
FCCP and after the addition of antimycin. Cell lysates were
prepared from each well at the end of the experiment for
the measurement of total protein content. Cells were sus-
pended in a mixture of 1X PBS and protease inhibitor cock-
tail (Roche) (1 mL/well) using a scraper then centrifuged at
13 000 × g for 15 min at 4C. The supernatant fluid was dis-
carded and cell pellets were resuspended in 50 L of RIPA
lysis buffer (Sigma) plus protease inhibitor cocktail (Roche)
then frozen at −80C. Lysates were thawed and then cen-
trifuged at 13 000 × g for 20 min to remove cell debris.
Protein concentration was measured using Bradford reagent
(Bio-Rad) against a standard curve constructed using BSA.
The measures of protein content were used to normalize the
data.
C© 2016 The Authors. Molecular Nutrition & Food Research Published by Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim. www.mnf-journal.com
1600574 (4 of 10) S. A. Aziz et al. Mol. Nutr. Food Res. 61, 2, 2017, 1600574
2.4 Western blotting
Cell lysates were prepared and protein concentration was
measured as described above. SDS-PAGE, transfer of proteins
to PVDFmembrane and probing with primary and secondary
antibodies to detect Sirt1 and-tubulinwere as described pre-
viously [21]. Signals for Sirt1 and -tubulin were measured
usingOdyssey software, as described previously [21], and data
were expressed as a ratio, which was then normalized to
control.
3 Results
We tested the effect of genistein on adipoytes using the well-
established 3T3-L1 cell line model, which is derived from
mouse fibroblasts and can be stimulated to differentiate to
acquire phenotypic features of white adipocytes [22, 23]. We
added genistein to the culture medium at concentrations of
10, 50, or 100 M from the point of inducing differentiation.
Compared with cells grown in parallel without the addition
of genistein we observed a change in appearance that was
induced more rapidly by higher concentrations of genistein.
Staining with the lipid-specific agent Oil Red O revealed a
redistribution of lipid from large droplets to a multilocu-
lar pattern. Typical images are shown in Fig. 1. This pat-
tern of lipid accumulation is a characteristic of brown/beige
adipocytes.
We next determined if genistein induced a shift in gene
expression profile consistent with adipocyte browning. One
response consistent with this action would be a reduction
in mRNAs corresponding to genes expressed at high levels
specifically in white adipocytes in cells treated with genistein.
We selected AcacaI (acetyl-CoA carboxylase), Fasn (fatty acid
synthase), Fabp4 (fatty acid binding protein 4), Lipe (hormone
sensitive lipase E), Rarres2 (retinoic acid receptor responder,
also known as chemerin) and Rten (resistin) as a test panel of
genes expressed at high levels in white adipocytes and mea-
sured the corresponding mRNAs (which we refer to as ACC,
Fasn, Fabp4,HSL, chemerin and resistin, respectively) by RT-
qPCR. The time- and concentration-dependence of the effects
measured (Fig. 2) were consistent with a model where genis-
Figure 1. 3T3-L1 cells on day 12 after induction of differentiation
to adipocytes in the presence of genistein at the concentrations
indicated stained using oil red O to reveal the distribution of
intracellular lipid. Scale bar 100 M.
tein initially promoted differentiation to white adipocytes but
subsequently induced browning. At 100 M genistein, the
highest concentration tested, the expression of all of these
genes was repressed at day 2, the first point of measurement,
whereas at 50 M gensitein there was an initial increase in
this mRNA, which reached a maximum at day 4, then fell to
levels lower than control by day 8. At the lower concentration
of 10 M, the maximum increase above control of all of these
transcripts induced by genistein was observed on day 8 and
no reduction in these transcripts compared with control had
been achieved by day 12.
A second response to genistein consistent with induc-
tion of adipocyte browning would be an increase in the
expression of genes that play a role in stimulating the de-
velopment of brown/beige adipocytes. We selected Cebpβ,
Ppargc1α and Sirt1 as a panel of genes for which this func-
tion has been attributed. Cebp has been shown to mediate
conversion of white to brown/beige adipocytes [1, 24], and
deacetylation and thus activation of PPAR-ɣ by Sirt1 caused
brown remodeling of white adipose tissue [25]. We com-
pared levels of mRNAs corresponding to these 3 genes in
cells treated with genistein with controls. Genistein caused
an increase in expression of all three markers although the
genes differed individually with respect to the time course
over which expression peaked (Fig. 2). This pattern of ex-
pression may reflect action at different points in the differ-
entiation process. Peaks in the expression of these genes
that preceded the point at which cells appeared to have
undergone full conversion to the beige adipocyte pheno-
type (i.e. 12 days after the introduction of genistein) are
consistent with these genes playing in role in differenti-
ation process. Cebp mRNA was increased by 100 M
genistein and, generally to a smaller extent, by 50 M genis-
tein progressively throughout the 12 day time course. At
100 M genistein Pgc1 mRNA reached a peak at day 4 and
had fallen to below levels in control cells by day 12, whereas at
50Mgenistein the increasewasmoremoderate and reached
a plateau over days 5–12. Sirt1 was induced substantially by
only 100 M genistein, and not by the lower concentrations
tested, in a profile that comprised an early initial peak (days 2–
4) followed by sustained more moderately enhanced expres-
sion. We also measured Sirt1 protein at day 10 of exposure
to 100 M genistein and observed an increase of approxi-
mately 12-fold over control (p < 0.001 by Student’s unpaired
t-test), according to quantification by densitometry of signals
on western blots using protein from 2 independent experi-
ments and measuring -tubulin as a loading control (Fig. 2;
panel B, inset). Thus, despite the response at the mRNA level
being more modest than for the CEPP and PGC1a, an in-
crease inSirt1 expression remains a likely important response
to genistein associated with its ability to induce adipocyte
browning.
To further determine if the reduced expression of genes
characteristic of white adipocytes and the increases in ex-
pression of genes associated with promoting brown/beige
adipocyte differentiation achieved at the higher concentration
C© 2016 The Authors. Molecular Nutrition & Food Research Published by Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim. www.mnf-journal.com
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Figure 2. The effect of genistein (10, 50, or 100 M) in 3T3-L1 cells on mRNAs corresponding to genes expressed at high levels in white
adipocytes (Panel A), genes that play a role in stimulating the development of brown/beige adipocytes (Panel B), or genes expressed
preferentially in brown/beige compared with white adipocytes (Panel C). Genistein was applied on induction of differentiation (d 0) and
measurements were made at d 12. Data are expressed relative to the reference genes Topo1 and NONO and normalised to control. Values
are mean ± SEM for n = 3–15 (derived from 3 replicates (wells) from 1 to 5 independent experiments). Statistical analysis was by one-way
ANOVA followed by Dunnett’s test. *p  0.05, **p  0.01, ***p  0.001. The inset panel in panel B shows a representative western blot of
protein extracted from cells at day 10 of treatment with 100 M genistein and from control cells probed with antibodies against Sirt1 and
-tubulin. Panel D provides an overview of the pattern of responses of these different categories of genes in the form of a heat map, where
red shading indicates an increased quantity of mRNA, yellow shading indicates no difference from control and green shading indicates a
reduced quantity of mRNA.
of genistein indicated a switch towards a brown/beige
adipocyte phenotype wemeasured the parallel effect on Ucp1
and CD137 (gene Tnfrsf91) mRNAs, both of which are ex-
pressed preferentially in brown/beige compared with white
adipocytes [12]. At a concentration of 100 M, genistein in-
duced a large (8-fold) increase in Ucp1 mRNA at day 12 and
also a sustained higher level (2 fold) of CD137 mRNA over
days 5–12 (Fig. 2). This large increase in Ucp1 mRNA in
particular is very robust evidence of the cells having the char-
acteristics of beige, rather than white, adipocytes since the
protein product is the major functional mediator of the res-
piratory uncoupling that is core to the distinctive phenotype
of brown or beige adipose tissue.
To determine if the change in appearance and gene ex-
pression profile of the cells was associated with effects onmi-
tochondrial function, specifically mitochondrial uncoupling,
we measured the oxygen consumption rate at day 12 of
treatment with genistein at baseline and after the sequen-
tial addition of oligomycin (to block ATP synthesis), TTNBP
(a retinoic acid analogue that activates UCP1), FCCP (respi-
ratory chain uncoupler) and antimycin A (inhibitor of res-
piratory chain complex III). Genistein increased baseline
oxygen consumption, and the proportional contribution of
proton leak to both basal and maximal respiratory capacity
was greater for cells exposed to genistein than for controls
(Fig. 3), revealing greater mitochondrial uncoupling in cells
C© 2016 The Authors. Molecular Nutrition & Food Research Published by Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim. www.mnf-journal.com
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Figure 3. The effect of genistein on the proportional contribution
of proton leak to basal and maximal respiratory capacity in 3T3-
L1 cells. The oxygen consumption rate by cells was measured on
day 12 after induction of differentiation under control conditions
or in the presence of 100 Mgenistein. Data are from n= 10 wells
for each condition. Statistical analysis was by Student’s t-test. **p
 0.01.
grown in the presence of genistein and hence consistent with
the characteristics of beige adipocytes.
On the basis that many reported cellular actions of genis-
tein appear to be mediated through estrogen receptors (ERs),
and based on evidence that genistein is an ER ligand [26,27],
we hypothesised that the effects of genistein we observed
were mediated through binding to the ER. We tested this hy-
pothesis by adding 100 M genistein to the medium used
to induce differentiation in the presence and absence of the
ER antagonist fulvestrant. With the exception of the response
of C/EBP, the presence of fulvestrant in the medium did
not affect the changes in mRNAs induced by genistein, and
fulvestrant in the absence of genistein had no effects
(Fig. 4). The increase in C/EBPmRNA induced by genistein
was slightly but significantly attenuated by fulvestrant, indi-
cating that at least a component of this response is mediated
through the classical ER pathway. Visual inspection of the
cells, including staining of the lipid content using Oil Red
O, indicating that fulvestrant had no effect on the genistein-
induced change in cell appearance (data not shown). Thus,
it appears that these effects of genistein are independent of
binding to ERs.
SIRT1 has pleiotropic roles in protecting against a variety
of features of ageing, including metabolic disease, and over-
expression in 3T3-L1 cells was reported to increase PPAR-Y
deactylation and induce a gene expression profile character-
istic of brown adipocytes [25]. Thus, we sought to determine
if SIRT1 is a hub through which the other effects of genistein
on gene expression we observed are mediated by measuring
the same mRNAs after including the SIRT1 inhibitor Ex-527
in the culture medium along with 100 M genistein. We
found that Ex-527 did not affect the response to genistein
of any of the tested genes that characterize white adipocytes
(Fig. 5). However, the expression of this panel of genes was
increased significantly when the cells were induced to dif-
ferentiate in the presence of Ex-527 alone, which indicates
the involvement of Sirt1 activity in regulating the process of
Figure 4. The effect in 3T3-L1 cells
of the estrogen receptor antago-
nist fulvestrant on responses to
genistein of mRNAs correspond-
ing to genes expressed at high
levels in white adipocytes (Panel
A) or genes that play a role in
stimulating the development of
brown/beige adipocytes or that
are expressed preferentially in
brown/beige comparedwithwhite
adipocytes (Panel B). Genistein
(100 M), with or without fulves-
trant (0.1 M), as indicated, was
applied on induction of differenti-
ation (day 0) and measurements
were made on day 12. Data are
expressed relative to the refer-
ence genes Topo1 and NONO and
normalised to control. Values are
mean ± SEM for n = 3. Statistical
analysis was by one-way ANOVA
followed by Bonferroni’ multiple
comparisons test. *p  0.05, **p
 0.01, ***p  0.001.
C© 2016 The Authors. Molecular Nutrition & Food Research Published by Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim. www.mnf-journal.com
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Figure 5. The effect in 3T3-
L1 cells of the Sirt1 inhibitor
Ex-527 on responses to genis-
tein of mRNAs corresponding
to genes expressed at high lev-
els in white adipocytes (Panel
A) or genes that play a role
in stimulating the development
of brown/beige adipocytes or
that are expressed preferen-
tially in brown/beige compared
with white adipocytes (Panel
B). Genistein (100 M), with or
without Ex-527 (10 M), as in-
dicated, was applied on induc-
tion of differentiation (day 0)
and measurements were made
on day 12. Data are expressed
relative to the reference genes
Topo1 and NONO and nor-
malised to control. Values are
mean ± SEM for n = 3. Statis-
tical analysis was by one-way
ANOVA followed by Bonferroni’
multiple comparisons test. *p 
0.05, **p  0.01, ***p  0.001.
lipogenesis. Importantly, inhibition of Sirt1 activity reduced
the genistein-mediated increase in UCP1 and C/EBP mR-
NAs, whereas they were unaffected by Sirt1 inhibition alone
(Fig. 5) revealing that at least a component of these responses
is via Sirt1.
4 Discussion
The present data show that application of the isoflavone genis-
tein during the differentiation process in the well-established
3T3-L1 adipocyte cell line model promotes the acquisition
of features of brown rather than white adipocytes. Classical
brown adipose tissue, such as observed in rodents, human
neonates and,more recently, adult humans derives from cells
that appear to be of distinct embryological origin to white adi-
pose tissue. Brown adipocytes, like skeletal myoblasts, derive
from Myf5-positive precursors, whereas beige adipocytes ap-
pear to derive from a Myf5-negative lineage, which is gener-
ally, though not exclusively, a feature also of white adipocytes.
[9–11,28] Cells with a lipid distribution, metabolic phenotype
and molecular signature more similar to brown than white
adipose tissue have been observed in depots of white adipose
tissue [11], leading to use of the term beige adipose tissue to
describe such depots, and hence the term beige adipocyte.
Given that 3T3-L1 is a fibroblast cell line (thus of Myf5-
negative origin), the cells of the brown-like phenotype and
profile we observe after treatment with genistein should be
considered “beige” rather than brown. The features induced
by genistein in this work that reveal the acquisition of features
of beige rather than white adipocytes comprise: i) a change
in lipid droplet distribution from the large droplets typical
of white adipose tissue to the multilocular pattern of smaller
droplets observed in brown/beige adipose tissue; ii) a change
in the expression profiles of genes in three categories – mark-
ers of white adipocytes (reduced), mediators of brown/beige
adipocyte differentiation (increased) and markers of beige
adipocytes (increased); iii) a change in mitochondrial oxygen
consumption consistent with greater respiratory uncoupling.
Reports including increased supraclavicular BAT volume
and activity detected using 2-deoxy-2-[18F]fluoro-D-glucose
([18F]FDG) PET/CT scanning in human subjects [2, 3] and
associated reduction in body fat mass achieved in response
to cold acclimation in humans [3], support an argument that
may be realistic to target nutritional strategies to promote the
acquisition of beige adipose tissue. Thus, the results of the
current in vitro work encourage in vivo studies in rodents
or humans to determine if such effects translate to whole
organism physiology. In this context, a pertinent question is
whether or not sufficient local concentrations of genistein are
achievable. Plasma concentrations of genistein measured in
cohorts with diets rich in isoflavones are typically in the or-
der of 0.1–1 M e.g. [29–31]. Intervention studies, including
our own work [32–34], have achieved plasma concentrations
of around 5 M with doses in the order of 10 mg. Doses
as high as 500 mg /day have been given safely [35, 36]. Ex-
trapolation suggests that such intakes could result in plasma
concentrations of up to 250 M, which is well in excess of the
extracellular concertation of 100 M we found to be effective
in promoting the beige adipocyte profile. Moreover, it is well-
recognised that effective concentrations of dietary agents that
achieve efficacy in cell culture models are generally much
higher than concentrations that can induce parallel effects in
vivo, and the lipophilic nature of the compound, combined
C© 2016 The Authors. Molecular Nutrition & Food Research Published by Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim. www.mnf-journal.com
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with an exposure period that will be much longer than can be
used in cell culture, makes accumulation at concentrations
in fatty tissues that exceed those in plasma very likely.
Our finding that genistein effects these changes in
adipocytes grown in vitro reveals a direct action on adipose
tissue and, importantly, provides a model in which to begin
to probe the underlying mediating molecular pathways. We
show that the effect of genistein is largely unaffected by inhi-
bition of the classical ER pathway. Thus, despite the fact that
gensistein has been shown to have action mediated through
the ER, these particular actions appear to be through other
pathways, which may include the G-protein coupled estro-
gen receptor (GPER) [37], through which genistein has been
shown to act (e.g. [38]).
An important finding was that the presence of the Sirt1 in-
hibitor Ex-527 curtailed substantially the effect of genistein to
increase UCP1mRNA, indicating that activation of Sirt1 may
be pivotal in the action of genistein to effect the switch to
the uncoupled mitochondrial phenotype that distinguishes
brown adipocytes from white adipocytes and is the core of
the mechanism through which excess energy is dissipated
by brown adipose tissue. Constituent with this observation,
Sirt1 overexpression increased PPAR-Y deactylation in 3T3-
L1 cells and induced a gene expression profile characteristic
of brown adipocytes [25]. These actions of Sirt1 to promote the
acquisition of brown adipose tissue, for which we here iden-
tify a dietary stimulator, are likely to be one of the pleiotropic
actions of Sirt1 responsible for its well-documented effects to
extend healthspan.
A pertinent question related to our findings is if these pu-
tative beige adipocytes derive from a precursor cell population
or through transdifferentiation of induced white adipocytes.
We replicated similar responses using different treatment
regimes, including application of genistein at later points af-
ter induction of differentiation (data not shown). However,
these observations do not resolve the issue, since it remains
entirely possible that, despite the abundance of cells with fea-
tures of white adipocytes in the culture when genistein was
introduced, the cells characterised by the features of beige
adipocytes arose from precursor cells, rather than through
transdifferentiation of this established white adipocyte pop-
ulation. Thus, our current work is focused on introducing
specific genetic markers that are trackable through the differ-
ent pathways of differentiation to resolve this question.While
efficacy of genistein to inducemetabolic benefits through this
process is not determined by which of the two mechanisms
applies, better understanding of the process will inform work
to identify dietary or pharmaceutical agents that are more
efficacious in inducing these changes.
A new study with the goal of identifying small molecules
that have the ability to achieve metabolic conversion of white
to brown adipocytes, using a human pluripotent stem cell-
derived adipocyte model, found the most efficacious agent to
be an inhibitor of Janus Kinase (JAK) activity [39], uncover-
ing for the first time a role for the JAK-STAT pathways in
control of this process. Like the present work, these findings
do not exclude either transdifferentiation of while adipocytes
or de novo induction of precursors of brown/beige adipocytes
as being the process through which the transformation was
achieved. However, like our own work, this important study
reveals molecular pathways to target in future in vivo work
aimed to translate the findings into achieving metabolic ben-
efit in humans, and thus contributing to reducing the burden
of obesity and metabolic disease.
In summary, we show that genistein effects in adipocytes
changes the appearance, gene expression profile and mito-
chondrial function that all point to a switch from white to
brown or beige phenotype. Importantly we show these ef-
fects in vitro, which reveals a direct action of the compound
on adipose tissue. Thus, in vitro models, such as the 3T3-L1
cell line used in the current work as well as stimulated human
pluripotent stem cell-derived mesenchymal progenitor cells
[39], provide a valuable tool to probe inmore detail the under-
lyingmediatingmolecular pathways. Such workmay identify
novel molecular targets for either dietary or pharmacological
intervention to promote the development of beige adipose
tissue in humans and hence improve metabolic health.
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